Back to search
Scientific Name: Finerenone
Brand Name: Kerendia
Company Owner: Not Available
Mechanism Of Action Finerenone is a non-steroidal selective mineralocorticoid receptor (MR) antagonist with no significant affinity or activity at androgen, progesterone, estrogen, and glucocorticoid receptors.
Description of the Drug: Finerenone is a nonsteroidal mineralocorticoid receptor antagonist indicated to lower the risk of eGFR decline, end stage kidney disease, cardiovascular death, heart attack, and hospitalization for heart failure in chronic kidney disease associated with type 2 diabetes.
Protein Data Bank: Not Available
Source: DrugBank Online – Retrieved 2023-01-23 from